Report ID |
130594 |
Drug Identification Number |
02212218 |
Brand name |
FORTAZ |
Common or Proper name |
Ceftazidime |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
CANCELLED POST MARKET |
Active Ingredient(s) |
CEFTAZIDIME |
Strength(s) |
1G |
Dosage form(s) |
POWDER FOR SOLUTION |
Route of administration |
INTRAMUSCULAR
INTRAVENOUS |
Packaging size |
All pack sizes / Tous les formats |
ATC code |
J01DD |
ATC description |
OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for discontinuation |
Business reasons |
Anticipated discontinuation date |
|
Actual discontinuation date |
2020-12-21 |
Remaining supply date |
2018-09-14 |
Discontinuation status |
Discontinued |
Discontinuation decision reversal |
No |
Information on remaining supply |
|
Company comments |
|
Health Canada comments |
|
Company contact information |
1-800-387-7374 |